CA2326603A1 - A drug composition containing sodium pravastatin - Google Patents
A drug composition containing sodium pravastatin Download PDFInfo
- Publication number
- CA2326603A1 CA2326603A1 CA002326603A CA2326603A CA2326603A1 CA 2326603 A1 CA2326603 A1 CA 2326603A1 CA 002326603 A CA002326603 A CA 002326603A CA 2326603 A CA2326603 A CA 2326603A CA 2326603 A1 CA2326603 A1 CA 2326603A1
- Authority
- CA
- Canada
- Prior art keywords
- drug composition
- cellulose
- composition according
- sodium pravastatin
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Crystallography & Structural Chemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1998/11172 | 1998-03-31 | ||
KR1019980011172A KR100281521B1 (ko) | 1998-03-31 | 1998-03-31 | 프라바스타틴나트륨이 함유된 약제 조성물 |
PCT/KR1999/000157 WO1999049896A1 (en) | 1998-03-31 | 1999-03-31 | A drug composition containing sodium pravastatin |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2326603A1 true CA2326603A1 (en) | 1999-10-07 |
Family
ID=19535615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002326603A Abandoned CA2326603A1 (en) | 1998-03-31 | 1999-03-31 | A drug composition containing sodium pravastatin |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1067967A1 (zh) |
JP (1) | JP2003517432A (zh) |
KR (1) | KR100281521B1 (zh) |
CN (1) | CN1298311A (zh) |
AU (1) | AU3057099A (zh) |
CA (1) | CA2326603A1 (zh) |
WO (1) | WO1999049896A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006105643A1 (en) * | 2005-04-08 | 2006-10-12 | Orbus Pharma Inc. | Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4658306B2 (ja) * | 2000-10-18 | 2011-03-23 | ナガセ医薬品株式会社 | 錠剤用医薬組成物 |
WO2003055991A1 (en) * | 2001-12-21 | 2003-07-10 | Rigshospitalet | Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux |
WO2003080026A1 (en) * | 2002-03-22 | 2003-10-02 | Ranbaxy Laboratories Limited | Controlled release drug delivery system of pravastatin |
EP1940391A4 (en) * | 2005-08-05 | 2010-01-20 | Orbus Pharma Inc | STABILIZED PHARMACEUTICAL COMPOSITIONS WITH EXTENDED RELEASE WITH AN HMG COA REDUCTASE INHIBITOR |
US7879821B2 (en) * | 2006-01-26 | 2011-02-01 | University Of Medicine And Dentistry Of New Jersey | Method for modulating inflammatory responses by altering plasma lipid levels |
BG934U1 (bg) * | 2006-12-14 | 2007-11-30 | "Софарма" Ад | Състав за твърда лекарствена форма, съдържащ правастатин |
GB0713707D0 (en) * | 2007-07-13 | 2007-08-22 | Generics Uk Ltd | Stable compositions |
CN101580466B (zh) * | 2008-05-12 | 2012-04-04 | 上海天伟生物制药有限公司 | 一种萘维太定的钠盐的制备方法 |
JP4890657B1 (ja) * | 2011-06-03 | 2012-03-07 | 小野薬品工業株式会社 | リマプロストとβ−シクロデキストリンを含有する錠剤 |
JP2013147488A (ja) * | 2011-12-21 | 2013-08-01 | Taisho Pharmaceutical Co Ltd | 固形製剤 |
JP6088872B2 (ja) * | 2013-03-22 | 2017-03-01 | サラヤ株式会社 | ラクトン型ソホロリピッドの分解が抑制されたソホロリピッド粉末 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3223232C2 (de) * | 1982-06-22 | 1984-04-05 | Wolfgang Dipl.-Phys. Dr.-Ing. 4800 Bielefeld Lindemann | Vorschubeinrichtung an einer mit einem umlaufenden Werkzeug versehenen Maschine, wie Schäl- oder Richtmaschine, für stangenförmiges Material, wie Wellen, Draht, Rohre o.dgl. |
DD232198A1 (de) * | 1984-07-13 | 1986-01-22 | Jenapharm Veb | Verfahren zur herstellung von festen komprimaten |
US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
TW224049B (zh) * | 1991-12-31 | 1994-05-21 | Sunkyong Ind Ltd |
-
1998
- 1998-03-31 KR KR1019980011172A patent/KR100281521B1/ko not_active IP Right Cessation
-
1999
- 1999-03-31 WO PCT/KR1999/000157 patent/WO1999049896A1/en not_active Application Discontinuation
- 1999-03-31 CA CA002326603A patent/CA2326603A1/en not_active Abandoned
- 1999-03-31 JP JP2000540858A patent/JP2003517432A/ja active Pending
- 1999-03-31 EP EP99912138A patent/EP1067967A1/en not_active Withdrawn
- 1999-03-31 CN CN99805551A patent/CN1298311A/zh active Pending
- 1999-03-31 AU AU30570/99A patent/AU3057099A/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006105643A1 (en) * | 2005-04-08 | 2006-10-12 | Orbus Pharma Inc. | Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
Also Published As
Publication number | Publication date |
---|---|
JP2003517432A (ja) | 2003-05-27 |
KR19990076302A (ko) | 1999-10-15 |
AU3057099A (en) | 1999-10-18 |
WO1999049896A1 (en) | 1999-10-07 |
CN1298311A (zh) | 2001-06-06 |
KR100281521B1 (ko) | 2001-02-15 |
EP1067967A1 (en) | 2001-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW492878B (en) | Tablet composition | |
US6936274B2 (en) | Storage stable thyroxine active drug formulations and methods for their production | |
KR101665395B1 (ko) | 6-플루오로-3-히드록시-2-피라진카르복사미드 함유 정제 및 조립분말 | |
KR101409087B1 (ko) | 광 안정성이 우수한 의약 제제 | |
JP3488475B2 (ja) | 活性物質の増大した溶解速度を有する薬剤組成物類の調製方法、および得られた組成物類 | |
CA2326603A1 (en) | A drug composition containing sodium pravastatin | |
RU2643325C2 (ru) | Жидкие композиции рацекадотрила | |
AU2010210123B2 (en) | Process for the preparation of a pharmaceutical composition comprising ezetimibe | |
JPH10330251A (ja) | コレステロール低下剤 | |
CN103800322A (zh) | 氟伐他汀钠组合物 | |
CN102008477B (zh) | 一种瑞舒伐他汀钙片药物组合物的制备方法 | |
US7052717B2 (en) | Storage stable thyroxine active drug formulations and methods for their production | |
AU2009324243B2 (en) | Pharmaceutical composition comprising ezetimibe and simvastatin | |
JP2019011322A (ja) | 医薬組成物 | |
JP6990470B2 (ja) | レナリドミド胃内滞留型徐放錠及びその調製方法 | |
KR100594606B1 (ko) | 속방성 경구 의약품 조성물 | |
KR20090086686A (ko) | 용출율이 개선된 실리마린 함유 약학적 조성물 및 이의제조방법 | |
FR2839888A1 (fr) | Complexes d'inclusion de fenofibrate et de cyclodextrine et composition pharmaceutique les renfermant | |
US20050069584A1 (en) | Diphenhydramine tannate solid dose compositions and methods of use | |
US20090247603A1 (en) | Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor | |
JP3947244B2 (ja) | 消化性潰瘍治療用製剤 | |
KR100514590B1 (ko) | 프라바스타틴나트륨 및 안정화제로서의 코폴리비돈을함유하는 약제 조성물 | |
FR2951945A1 (fr) | Composition pharmaceutique | |
ZA200100828B (en) | Compressed compositions comprising clarified xanthan gum. | |
LI et al. | 1526 Ljubljana (SI) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |